Journals / Türk Pediatri Arşivi / 2009 / Cilt: 44 - Sayı: 4

Serum ochratoxin A levels in children

Çocuklarda serum okratoksin A düzeyleri

Pages
138–142
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, the overall effect exposure to mycotoxins including OTA must be taken into consideration and this can have an impact on the nephrotoxicity seen in children.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Ochratoxin A (OTA) is a mycotoxin type with important toxic effects including nephrotoxicity, and its exposure route is through different sources of food.
📊
Key Findings & Data:Material and Method: Ochratoxin A levels were determined in the blood samples taken from children between 7-17 years (n=37) from Central Anatolia, Black Sea and Mediterranean Regions using ELISA technique.
💡
Conclusion & Impact:However, the overall effect exposure to mycotoxins including OTA must be taken into consideration and this can have an impact on the nephrotoxicity seen in children.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Ochratoxin A (OTA) is a mycotoxin type with important toxic effects including nephrotoxicity, and its exposure route is through different sources of food. The aim of this study is to determine the levels of OTA concentrations in children from different parts of Turkey, to assess the variances in different regions and to examine the possible relationship with sex, dietary habits and body mass index. Material and Method: Ochratoxin A levels were determined in the blood samples taken from children between 7-17 years (n=37) from Central Anatolia, Black Sea and Mediterranean Regions using ELISA technique. Serum OTA levels were determined as 0.59±0.08 ng/ml and daily OTA intake was determined as 0.82±0.11 ng/kg/day in whole study group. No differences were found in OTA levels in relation to sex. Results: Statistically significant differences were found between the regions and serum OTA levels were lower than the other regions in children living in Mediterranean Region. Conclusions: The OTA intake levels were below the levels of tolerable daily intake levels given by World Health Organization. However, the overall effect exposure to mycotoxins including OTA must be taken into consideration and this can have an impact on the nephrotoxicity seen in children.

Özet

Amaç: Okratoksin A (OTA), nefrotoksik etkileri başta olmak üzere önemli toksik etkilerinin olduğu bilinen ve gıdalar yoluyla temasın yaygın olduğu bir mikotoksin türüdür. Bu çalışmanın amacı, Türkiye’nin farklı bölgelerinde yaşayan çocuklarda serum OTA yoğunluklarının saptanması, günlük OTA alım düzeylerinin hesaplanması, bölgesel farklılıkların değerlendirilmesi ve cinsiyet, beslenme alışkanlıkları, vücut kitle indeksi (VKİ) ile olası ilişkisinin irdelenmesidir.Gereç ve Yöntem: İç Anadolu, Karadeniz ve Akdeniz Bölgesi’nde yaşayan 7-17 yaş aralığındaki çocuklardan (n=37) alınan kan örneklerinde serum OTA düzeyleri ELISA yöntemi ile ölçüldü.Bulgular: Tüm çalışma grubunda ortalama serum OTA düzeyi 0,59±0,08 ng/ml ve günlük OTA alım düzeyi 0,82±0,11 ng/kg/gün olarak belirlendi. Okratoksin A düzeyleri yönünden cinsiyete göre gruplar arasında anlamlı bir fark bulunmadı. Bölgeler arasında ise istatistiksel olarak önemli farklılıklar saptandı. Akdeniz Bölgesi’nde yaşayan çocukların serum OTA düzeyleri diğer bölgelere oranla daha düşüktü.Çıkarımlar: Hesaplanan tüm günlük OTA alım düzeyleri Dünya Sağlık Örgütü tarafından belirlenen kabul edilebilir günlük alım düzeylerinin altında bulundu. Ancak, OTA ile diğer mikotoksinlere de temasın sonucu olarak toplamsal bir etkinin olabileceği ve özellikle çocuklarda gözlenebilecek nefrotoksisitede önemli bir rolünün bulunabileceği dikkate alınmalıdır.

🔖

Cite This Article

AYDIN, S., SABUNCUOĞLU, S., ŞAHİN, G., GİRAY, B., ERKEKOĞLU, P. (2022). Serum ochratoxin A levels in children. Türk Pediatri Arşivi, Cilt: 44 - Sayı: 4, 138–142. https://ajindex.com/articles/641550

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Scott PM. Biomarkers of human exposure to ochratoxin A. Food Addit Contam 2005; 22: (Suppl 1) 99-107
  2. Creppy, EE. Update of survey, regulation and toxic effects of mycotoxins in Europe. Toxicol Lett 2002; 12: 19-28
  3. Fink-Gremmels J. Mycotoxins: Their implications for human and animal health. Vet Quart 1999; 21: 115-20
  4. Peraica M, Radiç B, Luciç A, Pavloviç M. Toxic effects of mycotoxins in humans. Bull World Health Organ 1999; 77: 754-66
  5. Bayman P, Baker JL. Ochratoxins: a global perspective. Mycopathologia 2006; 162: 215-23
  6. Pfohl-Leszkowicz A, Manderville RA. Ochratoxin A: an overview on toxicity and carcinogenicity in animals and humans. Mol Nutr Food Res 2007; 51: 61-99
  7. Atroshi F, Biese I, Saloniemi H, et al. Significance of apoptosis and its relationship to antioxidants after ochratoxin A administration in mice. J Pharm Sci 2000; 3: 281-91
  8. Soyoz M, Ozcelik N, Kilinc I, Altuntas I. The effects of ochratoxin a on lipid peroxidation and antioxidant enzymes: a protective role of melatonin. Cell Biol Toxicol 2004; 20: 213-9
  9. Peraica M, Domijan AM, Matasin M, et al. Variations of ochratoxin A concentration in the blood of healthy populations in some Croatian cities. Arch Toxicol 2001; 75: 410-4
  10. Palli D, Miraglia M, Saieva C, et al. Serum levels of ochratoxin A in healthy adults in Tuscany: correlation with individual characteristics and between repeat measurements. Cancer Epidemiol Biomarker & Prev 1999; 8: 265-9
  11. Thuvander A, Paulsen JE, Axberg K, et al. Levels of ochratoxin A in blood from Norwegian and Swedish blood donors and their possible correlation with food consumption. Food Chem Toxicol 2001; 39: 1145-51
  12. Gilbert J, Brereton P, MacDonald S. Assessment of dietary exposure to ochratoxin A in the UK using a duplicate diet approach and analysis of urine and plasma samples. Food Addit Contam 2001; 18: 1088-93
  13. Creppy EE, Castegnaro M, Grosse Y, Meriaux J, Manier C, Moncharmont P. Etude de l'ochratoxicose humaine dans trois regions de France: Alsace, Aquitaine, et region Rhene-Alpes. In: Human ochratoxicosis and its pathologies. Waller C. Creppy EE, Castegnaro M, Dirheimer G (eds). Montrouge: INSERM/John Libbey Eurotext, 1993: 147-58
  14. Scott PM, Kanhere SR, Lau BP, et al. Survey of Canadian human blood plasma for ochratoxin A. Food Addit Contam 1998; 15: 555-62
  15. Ueno Y, Maki S, Lin J, Furuya M, Suguira Y, Kawamura O. A 4-year study of plasma ochratoxin A in a selected population in Tokyo by immunoass